Future Generation Women fund managers from Minotaur, First Sentier and ECP shared their top picks ranging from technology companies to European banks.

Nephrocare Health IPO opens on December 10, 2025, aiming to raise ₹871.05 crore with a price band of ₹438 to ₹460 per share.

AMZN stock didn't do well in 2025, but AI and online advertising can lead to a comeback year for Amazon in 2026.

VFLO offers a robust blend of value and growth, outperforming the S&P 500 in rallies with lower drawdowns. Read why VFLO ETF ...

Union Civil Aviation Minister Ram Mohan Naidu said that the government considers it necessary to curtail the overall Indigo ...

Beyond Meat (NASDAQ: BYND) has been one of the worst stocks to own over the past five years, without a doubt. While investors ...

Citi has highlighted Jubilant Foodworks, Lupin, HPCL, ICICI Prudential Life and Voltas as its top contrarian stock picks for ...

Two blue-chip Canadian stocks to power your TFSA with tax-free dividends and steady growth you can own for decades.

One reason Take-Two is a good investment is that it generates revenue year-round from players spending money on in-game ...

Edelweiss’s push into smaller cities is part of the country’s financialization boom that has given rise to a growing equity ...

AppLovin (APP) stock is rated Strong Buy with 32% upside. Learn about its AI-driven ad tech, growth, and premium valuation.

With Canada set to drastically increase its defence spend in 2026, Calian is expected to see a major boon of new contracts.